Compared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on average more than five years younger at diagnosis and more than 30% more likely to die of their disease; that is according to a new analysis of data led by University of Maryland School of Medicine researchers.
This article was originally published on MedicalXpress.com

